2,973 research outputs found

    Penerapan Pembelajaran Dengan Bantuan Bertahap (Scaffolding) Untuk Meningkatkan Aktivitas Dan Prestasi Belajar Matematika Siswa Pada Materi Pokok Trigonometri Kelas X B Semester II Sman 1 Labuapi Tahun Pelajaran 2013/2014

    Get PDF
    : Mathematics learning process in X B class of senior high school number 1 Labuapi academic year 2013/2014 had some problems, students are not motivated to learn activity by their self, students meet difficulties in learning mathematics. Those problems causes the low of student's mathematics learning activity and achievement in X B class of senior high school number 1 Labuapi. Therefore, this research aims to solve that problems, by implementing scaffolding learning in teaching trigonometri material trough students in X B class of senior high school number 1 Labuapi academic year 2013/2014. The implementation of scaffolding learning method is held in five (5) steps. The result showed that an increase in the average value from cycle 1 to cycle 3, which is 66,56; 75,28; and 84,50. Mastery learning from cycle 1 to cycle 3 respectively are 33,33%, 66,67%, and 88,89%. In cycle 1, the mean score of students' learning activities is 10, 12, and 17, with quite active, active, and very active category. From this result it can be concluded that implementation of scaffolding learning can improve the mathematics activity and learning achievement in X Bclass students of senior high school number 1 Labuapi in material of trigonometry academic year 2013/2014

    Silicon Nanowire Immunosensor for Detection of 8-Hydroxy-2^|^apos;-Deoxyguanosine Oxidative Stress Cancer Biomarker

    Get PDF
    A silicon nanowire-based immunosensor has been developed to determine the presence of 8-hydroxy-2'-deoxyguanosine (8-OHdG). This research demonstrates a process for the detection of 8-OHdG, which is an oxidative stress biomarker, in which elevated concentrations in urine and saliva can act as an indicator of the presence of acute leukaemia, colorectal, breast, lung and prostate cancers. The detection of elevated levels of this biomarker is critical in determining the presence of various mutagenesis and can be used to diagnose early stage cancer before initial symptoms appear. The surface functionalization process has involved the attachment of diazonium salt to the silicon nanowire surface with further stage which involves the reduction of PhNO2 to PhNH2. The antibody targeted against 8-OHdG was subsequently bound to the amine NH2 modified grafted layer of a 370 nm width nanowire. The immunosensor was evaluated through the use of current/voltage electrical probe monitoring in which a 2 ÎŒg/ml concentration of 8-OHdG was detected. A further comparison with phosphate buffered saline solution added to the sensor was observed to be negligible. The antibody-functionalised SiNW sensor has been used to detect binding of the 8-OHdG biomarker to the SiNW surface within sixty-seconds of exposure, making this a rapid cancer biomarker test

    Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.

    Get PDF
    BACKGROUND: The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-AstraZeneca non-replicating viral-vectored vaccine (ChAdOx1 nCoV-19; AZD1222) and the Pfizer-BioNTech mRNA-based vaccine (BNT162b2) in residents of long-term care facilities in terms of PCR-confirmed SARS-CoV-2 infection over time since vaccination. METHODS: The VIVALDI study is a prospective cohort study that commenced recruitment on June 11, 2020, to investigate SARS-CoV-2 transmission, infection outcomes, and immunity in residents and staff in long-term care facilities in England that provide residential or nursing care for adults aged 65 years and older. In this cohort study, we included long-term care facility residents undergoing routine asymptomatic SARS-CoV-2 testing between Dec 8, 2020 (the date the vaccine was first deployed in a long-term care facility), and March 15, 2021, using national testing data linked within the COVID-19 Datastore. Using Cox proportional hazards regression, we estimated the relative hazard of PCR-positive infection at 0-6 days, 7-13 days, 14-20 days, 21-27 days, 28-34 days, 35-48 days, and 49 days and beyond after vaccination, comparing unvaccinated and vaccinated person-time from the same cohort of residents, adjusting for age, sex, previous infection, local SARS-CoV-2 incidence, long-term care facility bed capacity, and clustering by long-term care facility. We also compared mean PCR cycle threshold (Ct) values for positive swabs obtained before and after vaccination. The study is registered with ISRCTN, number 14447421. FINDINGS: 10 412 care home residents aged 65 years and older from 310 LTCFs were included in this analysis. The median participant age was 86 years (IQR 80-91), 7247 (69·6%) of 10 412 residents were female, and 1155 residents (11·1%) had evidence of previous SARS-CoV-2 infection. 9160 (88·0%) residents received at least one vaccine dose, of whom 6138 (67·0%) received ChAdOx1 and 3022 (33·0%) received BNT162b2. Between Dec 8, 2020, and March 15, 2021, there were 36 352 PCR results in 670 628 person-days, and 1335 PCR-positive infections (713 in unvaccinated residents and 612 in vaccinated residents) were included. Adjusted hazard ratios (HRs) for PCR-positive infection relative to unvaccinated residents declined from 28 days after the first vaccine dose to 0·44 (95% CI 0·24-0·81) at 28-34 days and 0·38 (0·19-0·77) at 35-48 days. Similar effect sizes were seen for ChAdOx1 (adjusted HR 0·32, 95% CI 0·15-0·66) and BNT162b2 (0·35, 0·17-0·71) vaccines at 35-48 days. Mean PCR Ct values were higher for infections that occurred at least 28 days after vaccination than for those occurring before vaccination (31·3 [SD 8·7] in 107 PCR-positive tests vs 26·6 [6·6] in 552 PCR-positive tests; p<0·0001). INTERPRETATION: Single-dose vaccination with BNT162b2 and ChAdOx1 vaccines provides substantial protection against infection in older adults from 4-7 weeks after vaccination and might reduce SARS-CoV-2 transmission. However, the risk of infection is not eliminated, highlighting the ongoing need for non-pharmaceutical interventions to prevent transmission in long-term care facilities. FUNDING: UK Government Department of Health and Social Care
    • 

    corecore